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Abstract
Background: Several dietary indices have been developed to measure overall diet quality, including the Healthy
Eating Index-2005 (HEI-2005), which measures adherence to the 2005 Dietary Guidelines from the USDA; the
Alternative Healthy Eating Index-2010 (AHEI-2010), which is based on foods and nutrients predictive of chronic
disease risk; and the Alternate Mediterranean Diet Score (aMDS), which is an index that characterizes traditional food
patterns of Mediterranean countries. Few studies have evaluated diet quality and ovarian cancer risk.
Methods: We assessed the associations of the HEI-2005, AHEI-2010, and aMDS with risk of epithelial ovarian cancer
prospectively among women in the Nurses’ Health Study. We used Cox proportional hazards models, adjusting for
known ovarian cancer risk factors.
Results: During 24 years of follow-up, we documented 696 incident epithelial ovarian cancer cases among 82,948
women with diet information. The multivariate adjusted hazard ratios (95% confidence interval; Ptrend) of epithelial
ovarian cancer comparing the highest with the lowest quintile were 1.03 (0.80-1.34; 0.77) for the AHEI-2010, 0.85
(0.65-1.12; 0.57) for the HEI-2005, and 0.91 (0.71-1.18; 0.44) for the aMDS.
Conclusions: We did not observe any clear association of three diet quality scores with ovarian cancer risk. Further
work should other metrics of evaluating diet quality that may be more relevant cancer risk.
Keywords: Alternative healthy eating index, Healthy eating index, Mediterranean diet score, Dietary pattern,
Ovarian cancer, Prospective cohort, Epidemiology
Introduction
Ovarian cancer is the fifth leading cause of cancer death
for women in the U.S. [1]. There are substantial geogra-
phic differences in ovarian cancer incidence rates across
the world, with the highest age-adjusted incidence rates
in developed countries (greater than 10 per 100,000), ex-
cept for Japan (6.4 per 100,000) [2]. One study reported
that daughters of Japanese immigrants to the US had
ovarian cancer incidence rates approaching the rates of
American Caucasians [3]. This suggests that non-genetic
and potentially modifiable risk factors, including diet-
ary factors, may influence ovarian carcinogenesis. While
ovarian cancer risk factors, including lack of oral contra-
ceptive use, lack of tubal ligation, postmenopausal hor-
mone therapy (HT), nulliparity, and a family history of
breast or ovarian cancer [2], have been identified, few diet-
ary factors have been consistently associated with the
disease [4].
Prior studies of diet and ovarian cancer generally
have evaluated only one food or nutrient at a time (e.g.
[5-10]). Diet quality scores are based on ap r i o r ide-
fined dietary patterns and are designed to evaluate an
individual’s overall diet, usually derived from adherence
to dietary guidelines. This measurement considers diet-
ary intake as an overall pattern, rather than evaluating
individual nutrients or food groups, which could lead
to important information that may represent new path-
ways for prevention. While most diet quality scores were
developed to predict cardiovascular outcomes [11,12],
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comes, such as ovarian cancer, that may have shared
etiologic pathways like inflammation [13-15]. Only one
study has evaluated a diet quality score and ovarian
cancer risk in a population-based case–control study;
no association was observed between the Healthy Eating
Index 2005 (HEI-2005) with risk [16].
Using Food Frequency Questionnaire (FFQ) data col-
lected from women in the Nurses’ Health Study (NHS),
we prospectively examined the associations between three
diet quality scores and risk of ovarian cancer. The diet-
quality scores examined were the Alternative Healthy
Eating Index 2010 (AHEI-2010), HEI-2005, and the Al-
ternate Mediterranean Diet Score (aMDS).
Methods
Study population
The NHS is a prospective cohort initiated in 1976, when
121,700 female registered nurses, 30 to 55 years of age
and residing in 11 U.S. states, completed an initial ques-
tionnaire. In 1984, we used a comprehensive FFQ to col-
lect dietary data from participants. The cohort has been
followed by biennially mailed questionnaires to update
covariate information and ascertain non-fatal incident
diseases. Deaths in the cohort are usually reported by
family or postal authorities. We also search for names of
non-responders in the National Death Index [17,18]. The
follow-up rate through June 2010 of women who com-
pleted the 1984 FFQ was 97% of the potential person-
years. Completion of the self-administered questionnaire
was considered to imply informed consent. This ana-
lysis was approved by the institutional review board at
the Brigham and Women’sH o s p i t a l .
Dietary measurement and FFQ
Dietary information was measured by a self-administered
semi-quantitative, 131-item FFQ, which was completed
every 2 to 4 years in the cohort. For each food, a portion
size was given and women were asked to choose from 9
intake frequencies, from never to ≥6 servings per day aver-
aging over the prior year’si n t a k e .C o n s u m p t i o no fc o l d
breakfast cereals, cooking oils, margarines, and multiple
vitamins was specified by brand. The validity of our FFQ
was evaluated by comparison with diet records in 192
NHS women; the average correlation for all foods was
0.63 [19-21].
Diet-quality scores
The HEI-2005 measures adherence to the USDA Dietary
Guidelines established in 2005, and is based on dietary
recommendations to ensure adequate nutrient intake
[22]; the components include total fruit, total vegetables,
total grains, milk, and meat and beans (Additional file 1:
Table S1). Additional components were created to repre-
sent whole fruit, dark green and orange vegetables and
legumes, whole grains, and oils. The score ranges from 0
to 100. The HEI-2005 is a valid measure of diet quality
in that the components are not strongly correlated with
the overall score and that “exemplary” menus obtain a
high score [23].
The AHEI-2010 was created as an alternative to the
HEI; this index was designed to incorporate foods and
nutrients that have been consistently associated with chro-
nic disease risk [24]. It includes vegetables, fruits, whole
grains, sugar-sweetened beverages (including fruit juices),
nuts/legumes, red/processed meat, trans fat, long-chain
omega-3 fatty acids, polyunsaturated fat, sodium, and al-
cohol (detailed in Additional file 1: Table S1); the score
ranges from 0 to 110.
The aMDS is an index that characterizes traditional
food patterns of Mediterranean countries. We used a
modified version of the original MDS constructed by
Trichopoulou and colleagues [25]. The aMDS considers
consumption of certain fatty acids, legumes, cereals,
fruits, nuts, vegetables, meat, dairy, and alcohol and
ranges from 0 to 10 (Additional file 1: Table S1).
Assessment of covariates
We collected extensive information on potential covari-
ates, including demographic characteristics, body mass
index (BMI), parity, oral contraceptive use, menopausal
status, HT use, tubal ligation, caffeine intake, family his-
tory of ovarian cancer (in first degree family members),
and other lifestyle factors. In general, most covariates
were updated every 2–4 years.
Identification of ovarian cancer cases
Ovarian cancer cases were identified either by self-report
of the disease on a biennial questionnaire or through
family members, the postal service, or the National
Death Index. Women or their next of kin were asked
for permission to obtain and review pathology reports
to confirm the diagnosis and classify cancers by behav-
ior (invasive vs. borderline), histologic type (e.g. epithe-
lial vs. not; serous/poorly differentiated, endometrioid,
clear cell, mucinous, other), and stage. For cases with-
out medical records we attempted to confirm the diag-
nosis through the appropriate state cancer registry. We
compared the pathology report histology with a review
of slides by a gynecologic pathologist for 215 cases.
The concordance was 98% for morphology and 83%
for histology [26].
Statistical analyses
At baseline we excluded women diagnosed with any cancer
other than non-melanoma skin cancer (n= 8,458), women
who reported a prior bilateral oophorectomy (n= 14,418),
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tion, 1,448 NHS participants died before start of follow-up
in 1986. Lastly, participants who did not complete the
1984 FFQ, had an implausible caloric intake in 1984 (<600
or >3,500 kcal/d), or left more than 70 items blank on the
1984 FFQ as well as participants who did not have dietary
score data available in 1984 (n=31,573) did not enter the
analysis until they had valid dietary data. Participants ac-
crued person-time from the return date of the 1986 ques-
tionnaire (or 2 years after the return of the first completed
FFQ with plausible caloric intake and no more than 70
items blank) until the earliest of the following events: ovar-
ian cancer diagnosis, any other cancer diagnosis (excluding
non-melanoma skin cancer), bilateral oophorectomy, pelvic
irradiation, death, or the end of follow-up (June 1, 2010).
Our primary exposure variables were cumulatively av-
eraged diet scores (in quintiles) assessed at least 2 years
before diagnosis (i.e., a 2-year lag) to account for poten-
tial influences of subclinical disease on dietary patterns.
With this method, we used the diet score values from
1984 as the exposure for the follow-up period from 1986
to 1988, the average of the 1984 and 1986 values as the
exposure for 1988 to 1992, the average of the 1984, 1986,
and 1990 values as the exposure for 1992 to 1996, and so
on. This approach allows the evaluation of long-term diet-
ary intake with reduced measurement error, but maintain-
ing true variations in diet [20]. We tested for linear trends
using the medians of the quintile dietary scores as an or-
dinal variable.
We used Cox proportional hazards models, to estimate
hazard ratios (HRs) and 95% confidence intervals (CIs)
associated with quintiles of diet-quality scores. We han-
dled time-varying covariates using the Andersen-Gill
data structure [27], with covariate values set at the time
the questionnaire was returned. To control for confoun-
ding by age, calendar time, and any 2-way interactions,
we stratified jointly by age at the start of each follow-up
period and calendar year of each follow-up period. The
time scale was in months since the return date for each
follow-up period. We tested proportional hazards as-
sumptions using likelihood ratio tests comparing mo-
dels with and without age (≤60, >60) interaction terms,
p-values were 0.74, 0.97, and 0.88 for AHEI-2010, HEI-
2005, and aMDS respectively.
For multivariate models, we adjusted for known and
putative risk factors for ovarian cancer, including age
(months), total energy intake (kcal/d), family history of
ovarian cancer (yes, no), tubal ligation (yes, no), BMI
(kg/m
2), parity (yes, no), number of additional pregnan-
cies (continuous), oral contraceptive use duration (0, >0-
1 yrs, >1-5 yrs, and >5 yrs), smoking (pack-years),
menopausal status (premenopausal/unknown, post-
menopausal), type and duration of PMH use (never
PMH user, past estrogen only user<5 yrs, past estrogen
only user≥5 yrs, current estrogen only user<5 yrs, cur-
rent estrogen only user ≥5 yrs, past E+P user<5 yrs,
past E+P user≥5y r s ,c u r r e n tE + Pu s e r < 5y r s ,a n d
current E +P y user≥5 yrs, past other user <5 yrs, past
other user≥5y r s ,c u r r e n to t h e ru s e r < 5y r s ,a n dc u r -
rent other user≥5 yrs,), age at menarche (years), hys-
terectomy (no, yes, unknown), unilateral oophorectomy
(no, yes, unknown), lactose intake (g/d), caffeine intake
(mg/d), and physical activity (0–3.8, >3.8-11.1, >11.1-
26.4, >26.4 MET-hrs/wk, missing).
Secondarily, we evaluated the relations between dietary
scores and specific subtypes of ovarian cancer using com-
peting risk proportional hazards models [28], including
invasive versus borderline, serous and poorly differenti-
ated versus non-serous, and rapidly fatal (death from
ovarian cancer within 3 years of diagnosis) versus less
aggressive [29]. The estimates for the dietary scores, as
well as tubal ligation, parity, and estrogen only HT use,
were allowed to vary by subtype based on prior ana-
lyses, whereas estimates for the remaining covariates were
constrained to a single effect estimate across subtypes. To
test for heterogeneity by tumor subtype, we compared a
model allowing the association for each dietary score to
vary by subtype to a model that with the same association
for all tumors. Analyses were conducted in SAS9.3 (SAS
Institute, Cary, NC, USA) and all analyses used two-sided
p-values.
Results
We documented 696 incident epithelial ovarian cancer
cases over 24 years of follow-up among 82,948 women.
At the midpoint of follow-up (1998), women with a high
AHEI-2010 score had lower BMI, higher physical activity,
lower caffeine intake, higher lactose intake, and smoked
less than those with lower scores (Table 1). Similar results
were observed for the HEI-2005 and aMDS (Additional
file 2: Table S2 and Additional file 3: Table S3). Based on
the 1984 FFQ, the correlation was 0.63 (P<.0 00 1) be -
tween HEI-2005 and AHEI-2010 scores, 0.43 (P<.0 00 1)
between HEI-2005 and aMDS, and 0.56 (P<.0 00 1) be -
tween AHEI-2010 and aMDS.
Overall, the AHEI-2010 was not statistically signi-
ficantly associated with epithelial ovarian cancer risk
(Ptrend=0.77). Compared to women with AHEI-2010≤
42, the multivariate adjusted HRs (95% CI) were 1.02
(0.78-1.32) for AHEI-2010>42-48, 1.23 (0.96-1.59) for
AHEI-2010>48-53, 1.11 (0.86-1.43) for AHEI-2010 >
53-59, and 1.03 (0.80-1.34) for AHEI-2010> 59 (Table 2).
The associations were similar by invasive versus bor-
derline, serous/poorly differentiated versus non-serous,
and rapidly fatal versus less aggressive tumors, (P het-
erogeneity=0.91, 0.98, and 0.71, respectively) and when
we restricted to women without a family history of
ovarian cancer.
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among women in the NHS
Quintiles of AHEI-2010 score
≤42 (N=11255) >42-48 (N= 12518) >48-53 (N=13169) >53-59 (N=13417) >59 (N=13273)
Mean (SD)
Age, years
* 62.4 (7.1) 63.4 (7.1) 64.1 (7.1) 64.8 (7.1) 65.6 (7.0)
Age at menarche, years
* 12.6 (1.4) 12.6 (1.4) 12.5 (1.4) 12.5 (1.4) 12.5 (1.4)
BMI, kg/m
2 27.0 (5.5) 26.8 (5.2) 26.7 (5.2) 26.5 (5.0) 26.0 (4.9)
Years of OC use
a 4.4 (3.8) 4.3 (3.8) 4.2 (3.9) 4.1 (3.9) 4.1 (4.0)
Parity
b 3.3 (1.6) 3.3 (1.6) 3.2 (1.5) 3.2 (1.5) 3.1 (1.4)
Physical activity, MET-hr/wk 12.5 (17.4) 14.9 (18.3) 17.2 (21.6) 18.9 (21.6) 23.8 (27.0)
Lactose intake, mg/day 12.7 (9.6) 13.2 (9.1) 13.6 (9.2) 14 (9.3) 13.9 (9.0)
Caffeine intake, mg/day 287.9 (201.6) 291.6 (202.0) 285.5 (199.4) 278.9 (198.8) 259.7 (198.3)
Calories per day 1859 (451) 1777 (460) 1739 (465) 1705 (468) 1684 (461)
Pack-years of smoking
c 31.8 (24.5) 27.6 (22.6) 25.3 (21.3) 22.7 (20.0) 20.5 (18.4)
E only HT use, years
d 6.0 (5.6) 6.0 (5.7) 6.4 (6.0) 6.4 (5.8) 6.6 (5.9)
E+ P HT use, years
e 5.0 (3.2) 5.0 (3.3) 5.2 (3.3) 5.2 (3.4) 5.3 (3.5)
Other HT use, years
f 3.0 (2.9) 2.9 (2.8) 3.0 (2.7) 3.0 (2.6) 3.1 (2.7)
Percent
Ever OC use 49 49 51 51 52
Smoking status
Never 47 45 44 42 40
Past 36 41 43 47 53
Current 17 14 12 10 7
Parous 95 95 95 94 93
Family history of ovarian cancer 3 3 3 3 3
Tubal ligation 21 21 21 21 21
Hysterectomy
No 73 75 74 75 74
Yes 22 21 23 22 22
Unknown 5 4 3 3 3
Unilateral oophorectomy
No 85 87 86 87 87
Yes 9 8 9 9 8
Unknown 6 5 4 4 4
Postmenopausal 92 92 93 93 92
Ever E only HT use 22 23 25 25 27
Ever E +P HT use 26 29 32 33 36
Ever other HT use 18 20 21 22 25
Values are standardized to the age distribution of the study population. Values of polytomous variables may not sum to 100% due to rounding.
aAmong ever OC users.
bAmong parous women.
cAmong ever smokers.
dAmong E only HT ever users.
eAmong E +P HT ever users.
fAmong other HT ever users.
*Value is not age adjusted.
Xie et al. Journal of Ovarian Research 2014, 7:112 Page 4 of 8
http://www.ovarianresearch.com/content/7/1/112No clear associations were observed for the HEI-2005
(Table 3) or the aMDS (Table 4) and ovarian cancer risk
or by tumor subtype. For example, women with HEI-
2005 >74 versus ≤ 56 [i.e., top versus bottom quintile]
had a HR of 0.85 (95% CI =0.65-1.12, P trend =0.57)
and women with aMDS>5.5 versus ≤2.6, the HR was
0.91 (95% CI=0.71-1.18; P trend =0.44). No heterogen-
eity was observed comparing different ovarian cancer
subtypes for the HEI-2005 (P heterogeneity ≥0.32) or
aMDS (P heterogeneity ≥ 0.41) and the results were simi-
lar when restricting to women without a family history
of ovarian cancer.
Discussion
In this large prospective study, we did not observe any
clear associations between three diet quality scores and
the risk of epithelial ovarian cancer. Further, no associ-
ation between the diet scores and risk were observed for
specific ovarian cancer subtypes defined by invasiveness,
histology, or tumor aggressiveness.
Our results are consistent with one small study of
t h eH E I - 2 0 0 5a n do v a r i a nc a n cer risk, which observed
no association [16] and a prospective cohort study of
the “Dietary Guidelines for Americans”, which also ob-
served no association [30]. Studies using statistical ap-
proaches, such as principal components analysis, to
assess dietary patterns in the population have not re-
ported consistent associations with ovarian cancer, al-
though there is some evidence that a pattern high in
fat and meat may be associated with increased risk
[31-34]. Other scores that include body size and phy-
sical activity in addition to diet factors inconsistently
Table 2 Hazard ratios (95% confidence intervals) for the association between 2-year lagged cumulative updated
AHEI-2010 and ovarian cancer from 1986 through 2010 among women in the NHS
AHEI-2010
N cases ≤42 >42-48 >48-53 >53-59 >59 P trend
# of cases 106 125 159 153 153
Person-years 294,805 294,224 293,771 293,500 293,282
Age-adjusted 696 1.00 (Ref) 1.04 (0.80,1.35) 1.29 (1.00,1.65) 1.17 (0.91,1.50) 1.12 (0.87,1.45) 0.30
Multivariable
* 696 1.00 (Ref) 1.02 (0.78,1.32) 1.23 (0.96,1.59) 1.11 (0.86,1.43) 1.03 (0.80,1.34) 0.77
Invasive* 592 1.00 (Ref) 1.10 (0.83,1.46) 1.34 (1.02,1.76) 1.17 (0.88,1.54) 1.00 (0.75,1.34) 0.90
Borderline* 57 1.00 (Ref) 0.72 (0.32,1.67) 0.79 (0.34,1.83) 0.87 (0.39,1.95) 0.87 (0.38,1.95) 0.88
Serous/poorly differentiated* 435 1.00 (Ref) 1.19 (0.86,1.65) 1.32 (0.96,1.82) 1.17 (0.84,1.62) 0.99 (0.71,1.39) 0.69
Non-serous* 148 1.00 (Ref) 0.65 (0.37,1.12) 0.93 (0.56,1.53) 0.79 (0.47,1.33) 0.87 (0.53,1.44) 0.83
Rapidly fatal* 247 1.00 (Ref) 1.11 (0.72,1.70) 1.18 (0.78,1.80) 1.06 (0.70,1.63) 0.93 (0.61,1.44) 0.60
Less aggressive* 274 1.00 (Ref) 1.15 (0.76,1.74) 1.55 (1.05,2.29) 1.24 (0.82,1.86) 1.02 (0.66,1.55) 0.98
*Adjustment factors are listed in the statistical analyses section.
P values for heterogeneity by tumor subtype were 0.91, 0.98, and 0.71 for invasive versus borderline, serous/poorly differentiated versus non-serous, and rapidly
fatal versus less aggressive tumors, respectively.
Table 3 Hazard ratios (95% confidence intervals) for the association between 2-year lagged cumulative updated
HEI-2005 and ovarian cancer from 1986 through 2010 among women in the NHS
HEI-2005
N cases ≤56 >56-63 >63-68 >68-74 >74 P trend
N cases 127 117 129 162 161
Person-years 294,749 294,665 294,337 293,738 292,082
Age-adjusted 696 1.00 (Ref) 0.82 (0.63,1.05) 0.85 (0.66,1.09) 0.99 (0.78,1.26) 0.92 (0.72,1.17) 0.98
Multivariable* 696 1.00 (Ref) 0.79 (0.61,1.03) 0.82 (0.63,1.06) 0.93 (0.72,1.20) 0.85 (0.65,1.12) 0.57
Invasive* 592 1.00 (Ref) 0.80 (0.60,1.05) 0.80 (0.60,1.05) 0.91 (0.69,1.20) 0.86 (0.64,1.15) 0.60
Borderline* 57 1.00 (Ref) 1.00 (0.45,2.24) 1.11 (0.50,2.43) 0.97 (0.42,2.20) 0.54 (0.20,1.43) 0.31
Serous/poorly differentiated* 435 1.00 (Ref) 0.81 (0.59,1.13) 0.91 (0.66,1.25) 0.91 (0.66,1.26) 0.90 (0.64,1.27) 0.79
Non-serous* 148 1.00 (Ref) 0.77 (0.46,1.31) 0.70 (0.41,1.21) 1.03 (0.62,1.69) 0.83 (0.49,1.43) 0.81
Rapidly fatal* 247 1.00 (Ref) 0.76 (0.51,1.14) 0.62 (0.40,0.94) 0.67 (0.44,1.02) 0.75 (0.50,1.13) 0.15
Less aggressive* 274 1.00 (Ref) 0.79 (0.52,1.18) 0.89 (0.60,1.32) 1.08 (0.73,1.59) 0.85 (0.556,1.29) 0.89
*Adjustment factors are listed in the Statistical Analyses section.
P values for heterogeneity by tumor subtype were 0.42, 0.95, and 0.32 for invasive versus borderline, serous/poorly differentiated versus non-serous, and rapidly
fatal versus less aggressive tumors, respectively.
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sociation in a European cohort [35] and a positive as-
sociation in a US study [30]. The lack of association
between these diet quality indices and ovarian cancer
risk is also consistent with prior research that many
of the individual components on the score, such as
fruits, vegetables and alcohol, were not strongly asso-
ciated with ovarian cancer risk, even in large pooled
analyses [36,37].
The major strengths of our study are the large number
of ovarian cancer cases; this enabled us to examine risk
by tumor characteristics. We also had comprehensive in-
formation on diet and important covariates. All this in-
formation was collected prospectively, which reduces the
potential for recall bias. In addition, dietary and covariate
data were assessed multiple times throughout follow-up,
which allows us to use long-term, cumulative average ex-
posures and thus reduce within person variation. To re-
duce potential reverse causation by sub-clinical ovarian
cancer influencing diet, we used a 2-year lagged analysis.
Finally, the dietary scores calculated in our study have a
wide distribution except for aMDS, suggesting that we
have a good representation of different dietary habits in
the US.
Several methodological issues should be considered in
interpreting our findings. First, the diet scores are calcu-
lated using arbitrary weights that are assigned to each
component, in part based on research on cardiovascular
disease risk. Second, we cannot distinguish brands or pro-
cessing methods for the food items on the FFQ, which
may cause misclassification in nutrient content. Finally,
self-reported diet assessed by FFQ has measurement
error, even though we validated it with dietary records
[21,38,39]. We expect the misclassification should be
random with respect to the outcome and would lead to
attenuation of associations.
Overall, in this large prospective cohort study among
US women, we did not observe any clear associations
with three scores of diet quality, AHEI-2010, HEI-2005,
or aMDS, with the risk of epithelial ovarian cancer, sug-
gesting that current dietary recommendations in the US
may not influence ovarian cancer incidence. Given the
limited number of ovarian cancer cases in individual co-
horts, a pooled analysis of prospective cohorts should be
considered to evaluate potential differential associations
for more rare tumor subtypes and consideration of other
dietary scores that better reflect factors associated with
cancer is warranted.
Additional files
Additional file 1: Table S1. Scoring criteria for AHEI-2010, HEI-2005,
and aMDS. All scoring criteria are calculated per 1000 kilocalories/day
unless specified, except saturated fat and SoFAAs, which are calculated as
percentage of total energy. Polyunsaturated fat does not include EPA or
DHA intake. For alcohol, the highest score was assigned to moderate,
and the worst score to heavy, alcohol consumers. Nondrinkers received a
score of 2.5.
Additional file 2: Table S2. Selected participant characteristics in 1998,
the midpoint during follow-up, by quintiles of HEI-2005 score among
women in the NHS. Values are standardized to the age distribution of the
study population. Values of polytomous variables may not sum to 100%
due to rounding. a Among ever OC users. b Among parous women.
c Among ever smokers. d Among E only HT ever users. e Among E+P HT
ever users. f Among other HT ever users. * Value is not age adjusted.
Additional file 3: Table S3. Selected participant characteristics in 1998,
the midpoint during follow-up, by quintiles of aMDS score among
women in the NHS. Values are standardized to the age distribution of the
study population. Values of polytomous variables may not sum to 100%
due to rounding. a Among ever OC users. b Among parous women.
c Among ever smokers. d Among E only HT ever users. e Among E+P HT
ever users. f Among other HT ever users. * Value is not age adjusted.
Table 4 Hazard ratios (95% confidence intervals) for the association between 2-year lagged cumulative updated aMDS
and ovarian cancer from 1986 through 2010 among women in the NHS
aMDS
N cases ≤2.6 >2.6-3.5 >3.5-4.5 >4.5-5.5 >5.5 P trend
N cases 134 119 148 136 159
Person-years 290,089 247,467 329,112 293,048 309,867
Age-adjusted 696 1.00 (Ref) 0.91 (0.71,1.17) 0.85 (0.67,1.07) 0.86 (0.68,1.10) 0.93 (0.74,1.18) 0.52
Multivariable* 696 1.00 (Ref) 0.90 (0.70,1.16) 0.83 (0.65,1.05) 0.85 (0.66,1.09) 0.91 (0.71,1.18) 0.44
Invasive* 592 1.00 (Ref) 0.93 (0.71,1.22) 0.80 (0.61,1.03) 0.86 (0.66,1.13) 0.86 (0.65,1.13) 0.25
Borderline* 57 1.00 (Ref) 0.76 (0.33,1.78) 0.93 (0.44,1.94) 0.44 (0.17,1.15) 0.81 (0.37,1.78) 0.37
Serous/poorly differentiated* 435 1.00 (Ref) 0.95 (0.69,1.31) 0.93 (0.69,1.26) 0.86 (0.63,1.18) 0.87 (0.63,1.20) 0.29
Non-serous* 148 1.00 (Ref) 0.71 (0.42,1.19) 0.52 (0.31,0.88) 0.72 (0.44,1.20) 0.85 (0.53,1.38) 0.62
Rapidly fatal* 247 1.00 (Ref) 0.78 (0.51,1.18) 0.71 (0.48,1.06) 0.83 (0.56,1.23) 0.66 (0.44,1.00) 0.11
Less aggressive* 274 1.00 (Ref) 1.25 (0.85,1.84) 0.87 (0.59,1.29) 0.88 (0.59,1.32) 1.04 (0.70,1.55) 0.59
*Adjustment factors are listed in the Statistical Analyses section.
P values for heterogeneity by subtype were 0.63, 0.89, and 0.41 for invasive versus borderline, serous/poorly differentiated versus non-serous, and rapidly fatal
versus less aggressive, respectively.
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